These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25446620)

  • 1. Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders.
    Bañuelos-Cabrera I; Valle-Dorado MG; Aldana BI; Orozco-Suárez SA; Rocha L
    Arch Med Res; 2014 Nov; 45(8):677-86. PubMed ID: 25446620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mast Cell Is an Early Activator of Lipopolysaccharide-Induced Neuroinflammation and Blood-Brain Barrier Dysfunction in the Hippocampus.
    Wang Y; Sha H; Zhou L; Chen Y; Zhou Q; Dong H; Qian Y
    Mediators Inflamm; 2020; 2020():8098439. PubMed ID: 32184702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.
    Desai BS; Monahan AJ; Carvey PM; Hendey B
    Cell Transplant; 2007; 16(3):285-99. PubMed ID: 17503739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Inflammation on the Blood-Neural Barrier and Blood-Nerve Interface: From Review to Therapeutic Preview.
    Skaper SD
    Int Rev Neurobiol; 2017; 137():29-45. PubMed ID: 29132542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-amplification of nigral degeneration in Parkinson's disease: a hypothesis.
    Ionov ID
    Int J Neurosci; 2008 Dec; 118(12):1763-80. PubMed ID: 18937118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes in neurologic and psychiatric disorders.
    Tsilioni I; Panagiotidou S; Theoharides TC
    Clin Ther; 2014 Jun; 36(6):882-8. PubMed ID: 24913029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease.
    Kempuraj D; Ahmed ME; Selvakumar GP; Thangavel R; Dhaliwal AS; Dubova I; Mentor S; Premkumar K; Saeed D; Zahoor H; Raikwar SP; Zaheer S; Iyer SS; Zaheer A
    Neuroscientist; 2020 Apr; 26(2):134-155. PubMed ID: 31092147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice.
    Stokely ME; Orr EL
    J Neurotrauma; 2008 Jan; 25(1):52-61. PubMed ID: 18355158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier alterations in ageing and dementia.
    Popescu BO; Toescu EC; Popescu LM; Bajenaru O; Muresanu DF; Schultzberg M; Bogdanovic N
    J Neurol Sci; 2009 Aug; 283(1-2):99-106. PubMed ID: 19264328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease.
    Jeynes B; Provias J
    J Neurosci Res; 2011 Jan; 89(1):22-8. PubMed ID: 21046564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium, neuronal death and neurological disease].
    Jiménez-Jiménez FJ; García-Ruiz PJ; de Bustos F
    Rev Neurol; 1996 Oct; 24(134):1199-209. PubMed ID: 8983715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells in neuroinflammation and brain disorders.
    Hendriksen E; van Bergeijk D; Oosting RS; Redegeld FA
    Neurosci Biobehav Rev; 2017 Aug; 79():119-133. PubMed ID: 28499503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
    Kamat PK; Kyles P; Kalani A; Tyagi N
    Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blood-brain barrier and epilepsy.
    Oby E; Janigro D
    Epilepsia; 2006 Nov; 47(11):1761-74. PubMed ID: 17116015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?
    Patel JP; Frey BN
    Neural Plast; 2015; 2015():708306. PubMed ID: 26075104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of stress and mast cells on brain metastases.
    Theoharides TC; Rozniecki JJ; Sahagian G; Jocobson S; Kempuraj D; Conti P; Kalogeromitros D
    J Neuroimmunol; 2008 Dec; 205(1-2):1-7. PubMed ID: 18977036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.